![]() |
Name |
BE-14324-113
|
Molecular Formula | C37H57NO14 | |
IUPAC Name* |
2-[[3,4,5-trihydroxy-6-[14-(4-hydroxy-5,6-dimethoxy-3-methylpyridin-2-yl)-3,5,7,12-tetramethyltetradeca-2,6,8,12-tetraen-4-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
|
|
SMILES |
CC=C(C)C(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C(C)C=C(C)C=CCC(C)=CCc1nc(OC)c(OC)c(O)c1C
|
|
InChI |
InChI=1S/C37H57NO14/c1-9-20(4)33(21(5)15-19(3)12-10-11-18(2)13-14-23-22(6)26(40)34(47-7)35(38-23)48-8)52-37-32(46)30(44)28(42)25(51-37)17-49-36-31(45)29(43)27(41)24(16-39)50-36/h9-10,12-13,15,21,24-25,27-33,36-37,39,41-46H,11,14,16-17H2,1-8H3,(H,38,40)/b12-10+,18-13+,19-15+,20-9+/t21-,24?,25?,27?,28?,29?,30?,31?,32?,33+,36?,37?/m1/s1
|
|
InChIKey |
ONDJAWAPNLRFQC-MPFQALCYSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 739.86 | ALogp: | 1.1 |
HBD: | 8 | HBA: | 15 |
Rotatable Bonds: | 16 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 230.1 | Aromatic Rings: | 3 |
Heavy Atoms: | 52 | QED Weighted: | 0.089 |
Caco-2 Permeability: | -5.425 | MDCK Permeability: | 0.00002960 |
Pgp-inhibitor: | 0.183 | Pgp-substrate: | 0.991 |
Human Intestinal Absorption (HIA): | 0.941 | 20% Bioavailability (F20%): | 0.024 |
30% Bioavailability (F30%): | 0.908 |
Blood-Brain-Barrier Penetration (BBB): | 0.185 | Plasma Protein Binding (PPB): | 65.57% |
Volume Distribution (VD): | 0.783 | Fu: | 9.49% |
CYP1A2-inhibitor: | 0.001 | CYP1A2-substrate: | 0.087 |
CYP2C19-inhibitor: | 0.005 | CYP2C19-substrate: | 0.633 |
CYP2C9-inhibitor: | 0 | CYP2C9-substrate: | 0.126 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.203 |
CYP3A4-inhibitor: | 0.072 | CYP3A4-substrate: | 0.112 |
Clearance (CL): | 1.182 | Half-life (T1/2): | 0.326 |
hERG Blockers: | 0.045 | Human Hepatotoxicity (H-HT): | 0.553 |
Drug-inuced Liver Injury (DILI): | 0.038 | AMES Toxicity: | 0.187 |
Rat Oral Acute Toxicity: | 0.049 | Maximum Recommended Daily Dose: | 0.085 |
Skin Sensitization: | 0.041 | Carcinogencity: | 0.048 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.004 |
Respiratory Toxicity: | 0.028 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003820 | ![]() |
0.806 | D0TC7C | ![]() |
0.335 | ||
ENC003819 | ![]() |
0.695 | D0I9HF | ![]() |
0.323 | ||
ENC002660 | ![]() |
0.613 | D0A8RX | ![]() |
0.318 | ||
ENC004855 | ![]() |
0.605 | D0Y3MO | ![]() |
0.286 | ||
ENC001847 | ![]() |
0.375 | D0YV1Q | ![]() |
0.281 | ||
ENC002949 | ![]() |
0.324 | D0P2IT | ![]() |
0.274 | ||
ENC002950 | ![]() |
0.324 | D07QQD | ![]() |
0.271 | ||
ENC003397 | ![]() |
0.316 | D07BSE | ![]() |
0.259 | ||
ENC002269 | ![]() |
0.315 | D04NDM | ![]() |
0.259 | ||
ENC001938 | ![]() |
0.315 | D04MRG | ![]() |
0.258 |